Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ketotifen fumarate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ketotifen 250micrograms/ml eye dps 0.4ml ud preserv free
1104020Y0AAABAB
|
Ketotifen Fumarate (Eye) | Ketotifen fumarate | Eye | 3,518 |
|
Ketotifen 1mg tablets
0304010AGAAACAC
|
Ketotifen Fumarate (Systemic) | Ketotifen fumarate | Respiratory System | 3,203 |
|
Ketotifen 250micrograms/ml eye drops
1104020Y0AAAAAA
|
Ketotifen Fumarate (Eye) | Ketotifen fumarate | Eye | 3,153 |
|
Ketofall 0.25mg/ml eye drops 0.4ml unit dose
1104020Y0BCAAAB
|
Ketofall | Ketotifen fumarate | Eye | 2,769 |
|
Ketotifen 1mg/5ml oral solution sugar free
0304010AGAAABAB
|
Ketotifen Fumarate (Systemic) | Ketotifen fumarate | Respiratory System | 751 |
|
Zaditen 250micrograms/ml eye drops
1104020Y0BBAAAA
|
Zaditen (Eye) | Ketotifen fumarate | Eye | 416 |
|
Zaditen 1mg tablets
0304010AGBBABAC
|
Zaditen (Systemic) | Ketotifen fumarate | Respiratory System | 105 |
|
Zaditen 1mg/5ml elixir
0304010AGBBACAB
|
Zaditen (Systemic) | Ketotifen fumarate | Respiratory System | 17 |
|
Ketotifen 1mg capsules
0304010AGAAAAAA
|
Ketotifen Fumarate (Systemic) | Ketotifen fumarate | Respiratory System | 16 |
|
Ketotifen 250micrograms/5ml oral suspension
0304010AGAAAEAE
|
Ketotifen Fumarate (Systemic) | Ketotifen fumarate | Respiratory System | No data available |
|
Ketotifen 500micrograms/5ml oral solution
0304010AGAAADAD
|
Ketotifen Fumarate (Systemic) | Ketotifen fumarate | Respiratory System | No data available |
|
Zaditen 1mg capsules
0304010AGBBAAAA
|
Zaditen (Systemic) | Ketotifen fumarate | Respiratory System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.